National Drug Strategy
National Drug Strategy

Management of patients with psychostimulant use problems: guidelines for general practitioners

Print page  Decrease text size  Increase text size

The aim of the guidelines is to assist general practitioners to identify patients who may be using psychostimulants; engage psychostimulant users in treatment; and identify and manage a range of adverse consequences of stimulant use including acute toxicity.

Published by Commonwealth Department of Health and Ageing
2007
The guidelines were originally published in 2004 and were reviewed and updated in 2007.

These guidelines have been developed to coincide with the update of the National Drug Strategy Monograph No 51, Second Edition, Models of intervention and care for psychostimulant users. Their purpose is to provide guidelines for general practitioners throughout Australia to effectively and safely manage individuals who are experiencing problems related to the use of psychostimulants, including psychostimulant and serotonin toxicity.

Management of patients with psychostimulant use problems: guidelines for general practitioners (PDF 193 KB)

Page currency, Latest update: 2007